---
figid: PMC6581679__fgene-10-00556-g003
figtitle: Non-canonical activation of HH-GLI signaling by oncogenic pathways
organisms:
- NA
pmcid: PMC6581679
filename: fgene-10-00556-g003.jpg
figlink: /pmc/articles/PMC6581679/figure/F3/
number: F3
caption: 'Non-canonical activation of HH-GLI signaling by oncogenic pathways. Schematic
  diagram of GLI1/2 and their positive (green) and negative regulators (red). EWS/FLI,
  SMAD3, miR-326 and miR-361 are only direct transcriptional regulators of GLI1/2.
  BRD4, HDACs and SRF-MKL1 regulate both GLI1/2 expression and transcriptional activity.
  See text for details. Abbreviations: AKT, protein kinase B; aPKCι/λ, atypical protein
  kinase Cι/λ; BRD4, bromodomain-containing protein 4; β-TrCP, β-transducin repeat-containing
  protein; DYRK1/2, dual specificity tyrosine-phosphorylation-regulated kinase 1/2;
  EWS/FLI, Ewing Sarcoma/Friend Leukemia Integration 1; GSK3β, glycogen synthase kinase
  3β; HDAC, histone deacetylase; IKKβ, inhibitor of nuclear factor kappa-B kinase
  subunit β; MEK, MAPK (Mitogen-activated protein kinase)/ERK (extracellular signal-regulated
  kinase) kinase; PI3K, phosphoinositide 3-kinase; PRMT1/5, protein arginine methyltransferases
  1/5; SRF-MKL1, serum response factor-megakaryoblastic leukemia 1; S6K1, ribosomal
  protein S6 kinase 1; WIP1, wild-type p53-induced phosphatase 1.'
papertitle: 'Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI
  Transcription Factors Beyond Smoothened.'
reftext: Silvia Pietrobono, et al. Front Genet. 2019;10:556.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.96368
figid_alias: PMC6581679__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6581679__F3
ndex: f18624e9-ded2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6581679__fgene-10-00556-g003.html
  '@type': Dataset
  description: 'Non-canonical activation of HH-GLI signaling by oncogenic pathways.
    Schematic diagram of GLI1/2 and their positive (green) and negative regulators
    (red). EWS/FLI, SMAD3, miR-326 and miR-361 are only direct transcriptional regulators
    of GLI1/2. BRD4, HDACs and SRF-MKL1 regulate both GLI1/2 expression and transcriptional
    activity. See text for details. Abbreviations: AKT, protein kinase B; aPKCι/λ,
    atypical protein kinase Cι/λ; BRD4, bromodomain-containing protein 4; β-TrCP,
    β-transducin repeat-containing protein; DYRK1/2, dual specificity tyrosine-phosphorylation-regulated
    kinase 1/2; EWS/FLI, Ewing Sarcoma/Friend Leukemia Integration 1; GSK3β, glycogen
    synthase kinase 3β; HDAC, histone deacetylase; IKKβ, inhibitor of nuclear factor
    kappa-B kinase subunit β; MEK, MAPK (Mitogen-activated protein kinase)/ERK (extracellular
    signal-regulated kinase) kinase; PI3K, phosphoinositide 3-kinase; PRMT1/5, protein
    arginine methyltransferases 1/5; SRF-MKL1, serum response factor-megakaryoblastic
    leukemia 1; S6K1, ribosomal protein S6 kinase 1; WIP1, wild-type p53-induced phosphatase
    1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - IGF1R
  - EGFR
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - GSK3B
  - MTOR
  - RPS6KB1
  - GLI1
  - GLI2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - NUMB
  - BTRC
  - DYRK1A
  - DYRK2
  - PPM1D
  - IKBKB
  - TP53
  - TP63
  - TP73
  - SOX9
  - SMARCB1
  - BRD4
  - DYRK1B
  - MIR326
  - MIR361
  - SMAD3
  - FLII
  - EWSR1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
